No insider purchase over the last 90 days. The latest, by ノムラ インターナショナル ピーエルシー(NOMURA INTERNATIONAL PLC), was filed 22 Nov 2022.
SanBio Company Limited: what insiders have been doing
SanBio Company Limited is a Health Care company. Its directors and officers file their transactions with EDINET (Japan FSA). From 1 November 2025 to 1 November 2026, the disclosure feed for SanBio Company Limited logged 9 filings by 3 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
For context, the typical company on the same exchange (median of 3,213 companies) published 3 filings over the same period, against 9 filings here. The full history, which starts in 2022, counts 304 purchases against 369 sales.
Over the last twelve months, not one insider purchase of SanBio Company Limited stock was filed. Between a trade and the moment it shows up on EDINET (Japan FSA), the median delay is 6 days. The shorter that gap, the sooner other investors can see what insiders have done.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
Since the insiders bought
- -35.0%Entry JP¥841 · Close at T+365 JP¥547
- Unknown-35.0%Entry JP¥841 · Close at T+365 JP¥547
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate SanBio Company Limited Hold (neutral), based on 5 analysts. Average price target: JP¥1,220.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended January 2026 · cache
- ShareXTKSEDINET:S100YRFF
- ShareXTKSEDINET:S100YI78
- ShareXTKSEDINET:S100YCFN
- ShareXTKSEDINET:S100XWQJ
- ShareXTKSEDINET:S100X8FZ
- ShareXTKSEDINET:S100X7GJ
- ShareXTKSEDINET:S100X579
- ShareXTKSEDINET:S100X2HB
- ShareXTKSEDINET:S100X2QF
- ShareXTKSEDINET:S100VSLK
- ShareXTKSEDINET:S100SKU6
- ShareXTKSEDINET:S100RJS9
- ShareXTKSEDINET:S100QK07
- ShareXTKSEDINET:S100Q9Z8
- ShareXTKSEDINET:S100Q36O
- ShareXTKSEDINET:S100Q2S9
- 30.1% of flowShareXTKSEDINET:S100PX3N
- 33.2% of flowShareXTKSEDINET:S100PVVV
- 36.6% of flowShareXTKSEDINET:S100PS2P
- ●Unknown5EDINET0.0% of flowShareXTKSEDINET:S100PQWR
- ●Unknown5EDINET0.0% of flowShareXTKSEDINET:S100PQG0
- ●Unknown5EDINET0.0% of flowShareXTKSEDINET:S100PPRR
- ▲Unknown0EDINET700 sharesShareXTKSEDINET:S100PODL:T7Canonical exit: 26 Dec 2022 (T+90)
- 66,600 sharesShareXTKSEDINET:S100PODL:T229Canonical exit: 19 Dec 2022 (T+90)
- ●Unknown5EDINET0.0% of flowShareXTKSEDINET:S100PODL
25 of 711 declarations
About SanBio Company Limited
SanBio Company is a company focused on the health and pharmaceutical sector, dedicated to developing innovative therapies. It is listed on the XTKS market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
